Nsaid-Gastropathy in Patients with Rheumatologic Diseases

Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/681

Full metadata record

DC Field	Value	Language
dc.contributor.author	Tuxtaeva Nigora.Xasanovna, Karimov Ma'rif Shakirovich,	-
dc.date.accessioned	2024-12-26T07:17:02Z	-
dc.date.available	2024-12-26T07:17:02Z	-
dc.date.issued	2024-12-16	-
dc.identifier.issn	2995-5319	-
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/681	-
dc.description.abstract	One of the most critical issues in modern rheumatology is the gastroduodenal side effects associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), which can lead to severe complications. NSAIDs most commonly have a damaging effect on the stomach and duodenum, a condition termed "NSAID-induced gastropathy" or "NSAID-gastroduodenopathy syndrome." "NSAID-gastropathy" was introduced in 1986 to distinguish specific gastric mucosal lesions associated with NSAID use from classic gastroduodenal ulcers.	en_US
dc.language.iso	en	en_US
dc.title	Nsaid-Gastropathy in Patients with Rheumatologic Diseases	en_US
dc.type	Article	en_US
Appears in Collections:	Articles

Files in This Item:

File	Description	Size	Format
23. Тухтаева Нигора Хасановна.pdf		751.45 kB	Adobe PDF	View/Open

DSpace JSPUI